PHARMACOLOGICAL CONTROL OF BLOOD-COAGULATION BY SYNTHETIC, LOW-MOLECULAR-WEIGHT INHIBITORS OF CLOTTING ENZYMES - NEW CONCEPT OF ANTICOAGULANTS

被引：0
|
作者：
MARKWARDT, F
机构：
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 1980年 / 1卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：153 / 157
页数：5
相关论文
共 50 条
  • [21] Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery?
    Rosencher, Nadia
    Bellamy, Lorenn
    Arnaout, Leila
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2009, 102 (04) : 327 - 333
  • [22] Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation
    Zmuda, K
    Neofotistos, D
    Ts'ao, C
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (05) : 725 - 731
  • [23] Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux, Volker
    Perzborn, Elisabeth
    Heitmeier, Stefan
    von Degenfeld, Georges
    Dittrich-Wengenroth, Elke
    Buchmueller, Anja
    Gerdes, Christoph
    Misselwitz, Frank
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) : 892 - 899
  • [24] Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes
    Gustafsson, D
    Antonsson, T
    Bylund, R
    Eriksson, U
    Gyzander, E
    Nilsson, I
    Elg, M
    Mattsson, C
    Deinum, J
    Pehrsson, S
    Karlsson, O
    Nilsson, A
    Sörensen, H
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (01) : 110 - 118
  • [25] THE EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN ON THE WHOLE-BLOOD ACTIVATED CLOTTING TIME AS COMPARED WITH STANDARD HEPARIN
    MESSMORE, HL
    FARID, S
    FABBRINI, N
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1111 - 1111
  • [26] MONITORING OF HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN IN HEMODIALYSIS USING A BEDSIDE WHOLE-BLOOD CLOTTING METHOD
    HAAF, B
    STEHLE, G
    DEMPFLE, CE
    SCHAFER, M
    HARENBERG, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1108 - 1108
  • [27] COMPARATIVE PHARMACOLOGICAL STUDIES ON A NEW LOW-MOLECULAR-WEIGHT HEPARIN (MERCKLE LMWH) AND ENOXAPARIN (R)
    MALINOWSKA, K
    KOZA, M
    IQBAL, O
    HOPPENSTEADT, D
    EMMERT, HK
    FAREED, J
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 891 - 891
  • [28] SUPERSULFATED HEPARIN FRAGMENTS, A NEW TYPE OF LOW-MOLECULAR-WEIGHT HEPARIN - PHYSICOCHEMICAL AND PHARMACOLOGICAL PROPERTIES
    NAGGI, A
    TORRI, G
    CASU, B
    PANGRAZZI, J
    ABBADINI, M
    ZAMETTA, M
    DONATI, MB
    LANSEN, J
    MAFFRAND, JP
    BIOCHEMICAL PHARMACOLOGY, 1987, 36 (12) : 1895 - 1900
  • [29] COAGULATION PARAMETERS AND INHIBITORS IN THE HEPARIN-PROPHYLAXIS OF THROMBOSIS - COMPARISON BETWEEN UNFRACTIONATED AND LOW-MOLECULAR-WEIGHT HEPARIN
    LORENZ, R
    BAUM, U
    BORN, P
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 967 - 967
  • [30] Measurement of whole blood factor Xa-activated clotting time during hemodialysis with low-molecular-weight heparin
    Mori M.
    Yoshitake S.
    Kitano T.
    Oda S.
    Noguchi T.
    Journal of Anesthesia, 1998, 12 (3) : 130 - 132
12345